EMIG is the UK research-based trade association that represents the interests of small to medium-sized BioPharmaceutical companies (SMEs).
EMIG member companies range from start-ups, whose prime focus is R&D, to highly developed businesses delivering essential products to patients, while continuing to invest heavily in the fight against disease.
EMIG has over 250 Members, of which, only c. 10% are members of other trade bodies. Consequently, EMIG is the sole representative body for 40% - 50% of the UK branded medicines industry.
EMIG Launches Paper on Opportunities for UK Healthcare Post Brexit:
'UK BioPharma - Adapting to a changing landscape to deliver a better global future'
The paper was presented to the EMIG Membership at the EMIG Quarterly Meeting in central London on Monday 5th September.
The full UK Data Science Report is available on this website.
For enquiries regarding the paper, please contact:
Leslie Galloway firstname.lastname@example.org 07736 144937
Dr Mark Edwards email@example.com 07887 831942